InvestorsHub Logo

Minnesinger

01/28/21 9:33 PM

#342044 RE: steelyeye #342043

Calling bullshit here...

per the company's latest investor update (1/20/21), Brilacidin has only been tested on the Washington and Italian variants of CV19.

In in vitro studies, Brilacidin was found to be a potent inhibitor of all variants of SARS-CoV-2, from the Washington to the Italian, from the English to the Danish and South African variants.



The quote referenced is false and unsubstantiated without qualified external citation.

There's a reason no link or citation was provided in the original post. Perhaps you're aware that unscrupulous actors will twist and embellish facts - rendering said facts as half-truths - for financial benefit?